Salas O’Brien welcomes Hughes Engineering & Consulting

Salas O’Brien announced today that Hughes Engineering & Consulting has joined the company, adding process design, project delivery, and Commissioning, Qualification, and Validation (CQV) expertise for pharmaceutical, life sciences, and biotechnology manufacturing.

The merger broadens Salas O’Brien’s capabilities to support all phases of the capital project lifecycle in these markets, as well as validation, process improvement, technology development, process scale-up, and process modeling and optimization. Based in Raleigh, North Carolina, the Hughes team will continue operating under its current leadership.

Hughes brings a tremendous reputation for innovative solutions and trusted client relationships. Together we will strengthen our ability to deliver innovative solutions for leading research and development clients in the pharma and biotechnology markets.

Darin AndersonChairman and CEO of Salas O’Brien

This marks the eighth merger for Salas O’Brien this year, creating a combined team of over 3,600 across more than 90 offices. The merger continues Salas O’Brien’s strategy of joining forces with leading-edge complementary firms that share a commitment to advancing society and improving communities through technical excellence and innovation.

We have a servant-leadership mindset focused on accountability, integrity, and designing for the best patient experience. Salas O’Brien aligns with our perspective and brings tremendous growth opportunities for team members. Together, we will deliver even more impact for the clients who depend on us and the patients that they serve.

Rob HughesCEO of Hughes Engineering & Consulting

Learn more about Salas O’Brien’s approach to mergers.

Topics

Mergers